Aldeyra The
ALDXNASDAQHealthcareBiotechnology
Previous close
$1.52
+$0.02 · +1.33%
ALDX company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
36
Expensive
Momentum
39
Weakening
Sentiment
47
Mixed
Risk resilience
30
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteAldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, including ADX 248, ADX 246, and other novel RASP modulators for the treatment of various diseases associated with RASP. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Todd C. Brady
- Listed since
- May 2, 2014
- Employees
- 6
Market position
Day range
Current $1.52
52-week range
Current $1.52
- Open
- $1.51
- Previous close
- $1.50
- Volume
- 1.1M
- 0.87× average
- Average volume
- 1.26M
- Average daily volume
- Market cap
- 91.69M USD
- Beta
- 1.2
- Market reference 1
- 50-day average
- $1.7737
- -14.30% below average
- 200-day average
- $3.192
- -52.38% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 256.58M USD
- P/E (TTM)
- -3.93×
- P/B (TTM)
- 2.42×
- P/S (TTM)
- 0×
- EV / EBITDA
- -8.1×
- Earnings yield
- -10.88%
- Free cash flow yield
- -10.72%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 0.00%
- Operating margin
- 0.00%
- Net margin
- 0.00%
- Return on equity
- -76.49%
- Return on assets
- -46.97%
- Return on invested capital
- -58.99%
Financial health
- Debt / equity
- 0×
- Current ratio
- 2.58×
Earnings
- EPS beat rate
- 55%
- 6 beats, 4 misses, 1 met estimate
- Average EPS surprise
- +2.79%
- 11 comparable reports
- Latest EPS result
- -0.09
- Estimate -0.09 · Miss by 2.86%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
19 ratingsALDX news
ALDX peers
ETFs holding ALDX
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI2.75M0.00%2.3T USD0.03%$378.24+0.44%
Vanguard Extended Market ETFVXF883.45K0.00%93.7B USD0.05%$245.53+0.82%
iShares Micro-Cap ETFIWC285K0.02%1.53B USD0.60%$198.39+1.10%
Vanguard Health Care ETFVHT256.81K0.00%20.9B USD0.09%$327.7+1.24%
Invesco RAFI US 1500 Small-Mid ETFPRFZ157.36K0.01%2.87B USD0.34%$55.89+0.87%
Invesco NASDAQ Future Gen 200 ETFQQQS95.85K0.42%22.98M USD0.20%$45.0826+1.10%
Dimensional - US Small Cap ETFDFAS42.2K0.00%15.92B USD0.26%$83.02+0.73%Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 2.75M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Extended Market ETFVXF- Market value
- 883.45K
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Micro-Cap ETFIWC- Market value
- 285K
- Weight
- 0.02%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $198.39+1.10%
Vanguard Health Care ETFVHT- Market value
- 256.81K
- Weight
- 0.00%
- AUM
- 20.9B USD
- Expense ratio
- 0.09%
- Price / 1D
- $327.7+1.24%
Invesco RAFI US 1500 Small-Mid ETFPRFZ- Market value
- 157.36K
- Weight
- 0.01%
- AUM
- 2.87B USD
- Expense ratio
- 0.34%
- Price / 1D
- $55.89+0.87%
Invesco NASDAQ Future Gen 200 ETFQQQS- Market value
- 95.85K
- Weight
- 0.42%
- AUM
- 22.98M USD
- Expense ratio
- 0.20%
- Price / 1D
- $45.0826+1.10%
Dimensional - US Small Cap ETFDFAS- Market value
- 42.2K
- Weight
- 0.00%
- AUM
- 15.92B USD
- Expense ratio
- 0.26%
- Price / 1D
- $83.02+0.73%
Continue in GoAI
Research ALDXresearch.disclaimer